Continuous Cervical Erector Spinae Plane Block Versus Interscalene Nerve Block in Shoulder Arthroscopic Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorNational Cheng-Kung University Hospital

About this trial

Shoulder arthroscopic surgery is associated with moderate to severe postoperative pain, which may hinder early mobilization and functional recovery. Interscalene block (ISB) is commonly used to provide effective analgesia but is frequently associated with hemidiaphragmatic paralysis due to phrenic nerve involvement. Cervical erector spinae plane block (ESPB) has been proposed as an alternative regional technique that may provide analgesia while reducing respiratory-related adverse effects. This randomized controlled trial aims to compare the analgesic efficacy and safety of cervical ESPB versus continuous ISB in patients undergoing shoulder arthroscopic surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients scheduled for elective shoulder arthroscopic surgery

Disqualifiers

Contraindications to regional analgesia

BMI >40

ASA physical status IV

history of drug or opioid abuse

Trial design

Design model

Parallel

Treatments tested in this trial

  • Continuous Cervical Erector Spinae Plane Block

    Procedure/Surgery

    An ultrasound-guided cervical erector spinae plane block with catheter placement will be performed. Local anesthetic will be administered through the catheter to provide continuous postoperative analgesia according to institutional protocol as part of a standardized multimodal analgesic regimen.

  • Continuous Interscalene Block

    Procedure/Surgery

    An ultrasound-guided interscalene block with catheter placement will be performed. Local anesthetic will be administered through the catheter to provide continuous postoperative analgesia according to institutional protocol as part of a standardized multimodal analgesic regimen.

  • No intervention

    Procedure/Surgery

    as observational group

Treatment groups

165 Participants
are divided into 3 treatment groups
Group A: Continuous Cervical Erector Spinae Plane BlockExperimental treatment 1 intervention
Group B: Continuous Interscalene BlockActive comparator 1 intervention
Group C: Single-Shot Interscalene BlockOther 1 intervention

Trial outcomes

Primary outcomes

1

Postoperative pain intensity within postoperative 24 hours

Postoperative pain intensity will be assessed using a 0-10 visual analogue scale (VAS) at 2, 6, 12, and 24 hours after surgery.

Time frame
2 hour, 6 hours, 12 hours, and 24 hours postoperatively

Secondary outcomes

1

Motor blockade severity

Motor blockade severity in the operated upper extremity will be assessed using a standardized muscle strength grading scale ranging from 0 to 5, where 0 indicates no muscle contraction and 5 indicates normal muscle strength.

Time frame
Up to 48 hours postoperatively
2

analgesic consumption

Rescue analgesic requirements and cumulative opioid consumption will be recorded and converted to oral morphine equivalent doses.

Time frame
48 hours
3

Adverse events

Adverse events will include postoperative nausea and vomiting, signs or symptoms of local anesthetic systemic toxicity, infection, neurologic symptoms, and catheter-related complications.

Time frame
7 days
4

Duration of motor blockade

The duration of motor blockade will be defined as the time from completion of surgery to recovery of normal motor function, defined as a muscle strength grade of 5 on the standardized 0-5 muscle strength scale, in the operated upper extremity.

Time frame
Up to 48 hours postoperatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: